Associate Scientist
Method Development, CMC
Confirmed live in the last 24 hours
Vancouver, BC, Canada
Experience Level
  • You are an innovator and ready to help new approaches to the discovery and development of therapeutics
  • You have a strong desire to support early antibody discovery work by developing ways to improve and speed up the discovery to CMC development to GMP manufacturing paradigm
  • You are ready to revolutionize therapeutic development and move at lightning speed to create a legacy in our industry
  • You are an outstanding communicator and teammate
  • You are highly motivated and excited about the opportunity to work with an inspired team on challenging problems that matter
  • A BSc degree in Analytical Chemistry, Biochemistry or related discipline with 5+ years experience or an MSc with 2-4 years of experience
  • Experience working in areas of therapeutic protein characterization in either academia or biotechnology
  • Strong data and time organization/management skills; proficiency in multi-tasking
  • Technical proficiency in separation based analytical method development and qualification including SEC, IEX, RP, HILIC, CE-SDS, SEC-MALS/QELS, and icIEF methods
  • Proficiency working with data acquisition platforms such as Empower, Compass, 32Karat, etc
  • Familiarity with electronic lab notebooks (Ex. Benchling), experimental data capture, and the associated 21 CFR part 11 compliance requirements
  • Demonstrated ability to learn, understand and master new experimental techniques
  • Knowledge of regulatory filings such as INDs, BLAs, IMPDs, etc would be advantageous
  • Prove yourself to be a problem-solver and team player with strong written and verbal communication skills
  • Familiarity with regulatory requirements as it pertains to CMC activities for monoclonal antibodies (FDA, EMA, ICH, etc)
Desired Qualifications
  • Experience with CMC analytical development of monoclonal antibodies or related biotherapeutic proteins is a plus
AbCellera Biologics
Company Overview
AbCellera Biologics is a biotechnology company that develops antibody therapeutics to improve patient outcomes.